Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

HWH International Inc.

HWH · Nasdaq · CIK 0001897245 · Healthcare

INSIDER SIGNAL

45.6 / 100

1 buyers · 1 purchase transaction lines · $500.0K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeModerate
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+7.0 / 35
Purchase size+14.5 / 25
Role+13.0 / 20
Recency+1.1 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Role scores low · most senior buyer: Chief Executive Officer (CEO, chair and 10% owners score lowest)
  • ⚠ Purchase activity is becoming less recent

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Alset Inc.; Chan Heng Fai AmbroseChief Executive Officer
●
Wong Shui YeungDirector
○
Wong Tat KeungDirector
○
Wu William Wai LeungDirector
○
Wei RongguoChief Financial Officer
○
Lim Sheng Hon DannyChief Operating Officer
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: Alset Inc.; Chan Heng Fai Ambrose · $500.0K
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-06-08–2026-06-08

Roles in the peak window: Chief Executive Officer. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

45.6 / 100

Latest recorded score

↓ -0.1 ptsversus the previous recorded snapshot
  1. 46.0
  2. 45.9
  3. 45.8
  4. 45.7
  5. 45.6

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

1Purchases
0Sales
8Other Form 4 lines
9SEC filings · 365 days
BUYING1 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER7 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
—
3M
—
6M
—
12M
—

Volatility & liquidity

Volatility
—
Beta
—
Avg daily value
—

Valuation

Market cap
—
P/E
—

Fundamentals

Profit margin
-303.4%
ROE
-100.4%
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-12-31 · Status: PASS

Short interest

The FINRA report lists no short interest for this ticker.

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-08Alset Inc.; Chan Heng Fai AmbrosePurchase (P)Common Stock250,000USD 2.00USD 500,000SEC filing ↗
2024-12-24Alset Inc.; Chan Heng Fai AmbrosePurchase (P)Common Stock1,300,000USD 0.45USD 585,000SEC filing ↗
2024-11-25Alset Inc.; Chan Heng Fai AmbrosePurchase (P)Common Stock4,411,764USD 0.68USD 3,000,000SEC filing ↗
2024-09-24Alset Inc.; Alset International Ltd; Chan Heng Fai AmbrosePurchase (P)Common Stock6,034,537USD 0.63USD 3,801,758SEC filing ↗
2024-01-10WOLVERINE ASSET MANAGEMENT LLCPurchase (P)Class A Common Stock200,165USD 10.66USD 2,133,759SEC filing ↗
2023-08-04Chan Heng Fai AmbrosePurchase (P)Class A Common Stock410USD 7.39USD 3,030SEC filing ↗
2023-08-03Chan Heng Fai AmbrosePurchase (P)Class A Common Stock31,871USD 7.68USD 244,694SEC filing ↗
2023-08-02Chan Heng Fai AmbrosePurchase (P)Class A Common Stock32,519USD 6.53USD 212,381SEC filing ↗

Form 4 evidence

9 transaction lines in the latest 365-day window; 36 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-07Wu William Wai LeungAward / grant (A)Common Stock40,000USD —USD —SEC filing ↗
2026-08-07Wong Tat KeungAward / grant (A)Common Stock20,000USD —USD —SEC filing ↗
2026-08-07Wong Shui YeungAward / grant (A)Common Stock20,000USD —USD —SEC filing ↗
Show recent Form 4 evidence (9 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-07Wu William Wai LeungAward / grant (A)Common Stock40,000USD —USD —SEC filing ↗
2026-08-07Wong Tat KeungAward / grant (A)Common Stock20,000USD —USD —SEC filing ↗
2026-08-07Wong Shui YeungAward / grant (A)Common Stock20,000USD —USD —SEC filing ↗
2026-08-07Wei RongguoAward / grant (A)Common Stock50,000USD —USD —SEC filing ↗
2026-08-07Lim Sheng Hon DannyAward / grant (A)Common Stock135,000USD —USD —SEC filing ↗
2026-08-07Chan Heng Fai AmbroseAward / grant (A)Common Stock1,480,000USD —USD —SEC filing ↗
2026-08-05Alset Inc.; Alset International Ltd; Chan Heng Fai AmbroseJ (J)Common Stock320,000USD —USD —SEC filing ↗
2026-06-08Alset Inc.; Chan Heng Fai AmbrosePurchase (P)Common Stock250,000USD 2.00USD 500,000SEC filing ↗
2025-11-26Chan Heng Fai AmbroseAward / grant (A)Common Stock1,000,000USD —USD —SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerHWH
CIK0001897245
SectorHealthcare
Industry— Yahoo Finance
SEC SIC5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
ExchangeNasdaq

Data coverage

Local Form 4 history36 transaction lines from 2023-05-01 to 2026-08-07
14 P purchase lines · 6 S sale lines · 16 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.